课题基金 / 基金详情

'Two-Step Authentication' for Optimal Prostate Cancer Risk Determination: An "Extracellular Vesicle"-Based Liquid Biopsy Followed by Multi-Parametric MRI.

'Two-Step Authentication' for Optimal Prostate Cancer Risk Determination: An "Extracellular Vesicle"-Based Liquid Biopsy Followed by Multi-Parametric MRI.
用于最佳前列腺癌风险确定的“两步验证”：基于“细胞外囊泡”的液体活检，随后进行多参数 MRI。
批准号：
462401
负责人：
Leong Hon Sing
金额：
$119.26万
依托单位：
Sunnybrook Research Institute (Toronto, Ontario)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2022
资助国家：
加拿大
项目状态：
未结题
起止时间：
2022-03-01 至 2027-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=462401&lang=en
关键词：
"Liquid Biopsy" Benign Prostatic Hyperplasia Extracellular Vesicles Gleason Group Score Multi-Parametric Magnetic Resonance Pi-Rads V2 Prostate Cancer Prostate Needle Biopsy Radiology Risk Stratification

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Early detection and diagnosis of prostate cancer still needs significant improvement. Too many men are erroneously submitted to an invasive biopsy procedure that will reveal no evidence of cancer. More than half of biopsy procedures done in Canada and the
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金